Disclosure, Social Harm, and Support Activation Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorYale University
About this trial
To characterize how disclosure of suicide or severe emotional distress functions socially in rural eastern Uganda: who people have disclosed to, what happened, what harms resulted, who they would want involved in future support, and under what conditions they would want support activated on their behalf.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
self-reports a history of suicidal ideation or attempt,
self-reports a period of severe depressive distress (persistent sadness, hopelessness, withdrawal lasting ≥2 weeks), or
has previously disclosed suicidal thoughts or severe distress to another person
Able and willing to provide informed consent
Disqualifiers
Currently in acute suicidal crisis with intent or plan (activate safeguarding protocol, defer enrollment to after stabilization)
Unable to engage in a 25-30 minute survey without significant distress
Trial population
The study population consists of adults aged 18 years or older living in rural eastern Uganda who have experienced suicidal thoughts or a suicide attempt, a period of severe depressive distress lasting at least two weeks, or prior disclosure of suicidality or severe emotional distress. Participants will be recruited through outpatient clinic visits, community health worker referrals, and participant-mediated referrals. Individuals who are currently in an acute suicidal crisis with intent or a plan will be referred for immediate support and enrolled only after stabilization, while those unable to consent or complete the survey safely will be excluded or reconsidered later. The study plans to enroll 80-100 participants in the quantitative survey, with 20-30 purposively selected for qualitative interviews representing helpful, harmful or forced, mixed, and non-disclosure experiences
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
Survey Questionnaire
Other interventionSurvey capturing disclosure history (who was told, when, why, how), disclosure outcomes (what happened, what harms resulted), disclosure comfort (willingness to tell specific people under specific conditions), social harm inventory (lifetime and recent harms following disclosure), preferred support persons and conditions for activation, and willingness to be screened
Treatment groups
361 Participants
are divided into 3 treatment groupsGroup A: Helpful Disclosure Group1 intervention
Group B: Harmful Disclosure Group1 intervention
Group C: Never Disclosed Group1 intervention
Trial outcomes
Primary outcomes
1
Social Harm Inventory
A 10-item inventory of adverse social harms experienced after disclosure: family anger/punishment, community gossip, police involvement, confinement/restraint, forced traditional healing, loss of employment or income, relationship termination, public humiliation, unwanted religious intervention, and other. Each endorsed item rated on a likert scale for severity (mild, moderate, severe) and recency (past month, past year, over a year ago). These likert scales maybe be interpreted numerically (1-mild, 2- moderate, 3- severe and 1-over a year ago, 2- past year, 3- past month) with a higher score indicating higher severity and recency of each of the measured social harms. Scores range from 1 to 3 on each severity and recency scale.
Time frame
Through 60 minute survey and interviewSecondary outcomes
1
Disclosure Comfort
Willingness to disclose suicidal thoughts or severe distress to each of 9 potential support persons (spouse, parent, sibling, close friend, religious leader, CHW, health worker, traditional healer, employer/teacher) rated on a 4-point scale (1-definitely would, 2- might, 3- probably not, 4- definitely not). Scores on this Likert Scale range from 1-4 with lower scores indicating high comfort disclosing to a sub-group of support persons and higher scores indicating low comfort of disclosure.
Time frame
Through 60 min Interview and survey period2
Support Activation Preferences
The core Connection Prescription module. For each potential support person, participants indicate: (a) whether they would want that person contacted if they were in crisis, (b) under what conditions (only with my permission, if I'm in danger, anytime), (c) what they would want that person to do (listen, stay with me, take me to clinic, pray with me, nothing), and (d) who should NEVER be told. This directly parameterizes the Connection Prescription. Question (a) is a discrete choice response with yes scored as '1' and no scored as '0'. TQuestion (b) is rated on a likert scale ranging 1-3 with 1 indicating more consistent comfort with supporter activation and 3 indicating activation in only particular circumstances. Question (c) will allow participants to select mutli-items form the scale and question (d) will allow participants to fill in the blank thus not being scored.
Time frame
Through 60 minute interview and survey periodSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov